Cargando…

Optimizing antimicrobial prescribing: Are clinicians following national trends in methicillin-resistant staphylococcus aureus (MRSA) infections rather than local data when treating MRSA wound infections

BACKGROUND: Clinicians often prescribe antimicrobials for outpatient wound infections before culture results are known. Local or national MRSA rates may be considered when prescribing antimicrobials. If clinicians prescribe in response to national rather than local MRSA trends, prescribing may be im...

Descripción completa

Detalles Bibliográficos
Autores principales: Schweizer, Marin L, Perencevich, Eli N, Eber, Michael R, Cai, Xueya, Shardell, Michelle D, Braykov, Nikolay, Laxminarayan, Ramanan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853220/
https://www.ncbi.nlm.nih.gov/pubmed/24128420
http://dx.doi.org/10.1186/2047-2994-2-28
_version_ 1782478800422961152
author Schweizer, Marin L
Perencevich, Eli N
Eber, Michael R
Cai, Xueya
Shardell, Michelle D
Braykov, Nikolay
Laxminarayan, Ramanan
author_facet Schweizer, Marin L
Perencevich, Eli N
Eber, Michael R
Cai, Xueya
Shardell, Michelle D
Braykov, Nikolay
Laxminarayan, Ramanan
author_sort Schweizer, Marin L
collection PubMed
description BACKGROUND: Clinicians often prescribe antimicrobials for outpatient wound infections before culture results are known. Local or national MRSA rates may be considered when prescribing antimicrobials. If clinicians prescribe in response to national rather than local MRSA trends, prescribing may be improved by making local data accessible. We aimed to assess the correlation between outpatient trends in antimicrobial prescribing and the prevalence of MRSA wound infections across local and national levels. METHODS: Monthly MRSA positive wound culture counts were obtained from The Surveillance Network, a database of antimicrobial susceptibilities from clinical laboratories across 278 zip codes from 1999–2007. Monthly outpatient retail sales of linezolid, clindamycin, trimethoprim-sulfamethoxazole and cephalexin from 1999–2007 were obtained from the IMS Health Xponent(TM) database. Rates were created using census populations. The proportion of variance in prescribing that could be explained by MRSA rates was assessed by the coefficient of determination (R(2)), using population weighted linear regression. RESULTS: 107,215 MRSA positive wound cultures and 106,641,604 antimicrobial prescriptions were assessed. The R(2) was low when zip code-level antimicrobial prescription rates were compared to MRSA rates at all levels. State-level prescriptions of clindamycin and linezolid were not correlated with state MRSA rates. The variance in state-level prescribing of clindamycin and linezolid was correlated with national MRSA rates (clindamycin R(2) = 0.17, linezolid R(2) = 0.22). CONCLUSIONS: Clinicians may rely on national, not local MRSA data when prescribing clindamycin and linezolid for wound infections. Providing local resistance data to prescribing clinicians may improve antimicrobial prescribing and would be a possible target for future interventions.
format Online
Article
Text
id pubmed-3853220
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38532202013-12-07 Optimizing antimicrobial prescribing: Are clinicians following national trends in methicillin-resistant staphylococcus aureus (MRSA) infections rather than local data when treating MRSA wound infections Schweizer, Marin L Perencevich, Eli N Eber, Michael R Cai, Xueya Shardell, Michelle D Braykov, Nikolay Laxminarayan, Ramanan Antimicrob Resist Infect Control Research BACKGROUND: Clinicians often prescribe antimicrobials for outpatient wound infections before culture results are known. Local or national MRSA rates may be considered when prescribing antimicrobials. If clinicians prescribe in response to national rather than local MRSA trends, prescribing may be improved by making local data accessible. We aimed to assess the correlation between outpatient trends in antimicrobial prescribing and the prevalence of MRSA wound infections across local and national levels. METHODS: Monthly MRSA positive wound culture counts were obtained from The Surveillance Network, a database of antimicrobial susceptibilities from clinical laboratories across 278 zip codes from 1999–2007. Monthly outpatient retail sales of linezolid, clindamycin, trimethoprim-sulfamethoxazole and cephalexin from 1999–2007 were obtained from the IMS Health Xponent(TM) database. Rates were created using census populations. The proportion of variance in prescribing that could be explained by MRSA rates was assessed by the coefficient of determination (R(2)), using population weighted linear regression. RESULTS: 107,215 MRSA positive wound cultures and 106,641,604 antimicrobial prescriptions were assessed. The R(2) was low when zip code-level antimicrobial prescription rates were compared to MRSA rates at all levels. State-level prescriptions of clindamycin and linezolid were not correlated with state MRSA rates. The variance in state-level prescribing of clindamycin and linezolid was correlated with national MRSA rates (clindamycin R(2) = 0.17, linezolid R(2) = 0.22). CONCLUSIONS: Clinicians may rely on national, not local MRSA data when prescribing clindamycin and linezolid for wound infections. Providing local resistance data to prescribing clinicians may improve antimicrobial prescribing and would be a possible target for future interventions. BioMed Central 2013-10-15 /pmc/articles/PMC3853220/ /pubmed/24128420 http://dx.doi.org/10.1186/2047-2994-2-28 Text en Copyright © 2013 Schweizer et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Schweizer, Marin L
Perencevich, Eli N
Eber, Michael R
Cai, Xueya
Shardell, Michelle D
Braykov, Nikolay
Laxminarayan, Ramanan
Optimizing antimicrobial prescribing: Are clinicians following national trends in methicillin-resistant staphylococcus aureus (MRSA) infections rather than local data when treating MRSA wound infections
title Optimizing antimicrobial prescribing: Are clinicians following national trends in methicillin-resistant staphylococcus aureus (MRSA) infections rather than local data when treating MRSA wound infections
title_full Optimizing antimicrobial prescribing: Are clinicians following national trends in methicillin-resistant staphylococcus aureus (MRSA) infections rather than local data when treating MRSA wound infections
title_fullStr Optimizing antimicrobial prescribing: Are clinicians following national trends in methicillin-resistant staphylococcus aureus (MRSA) infections rather than local data when treating MRSA wound infections
title_full_unstemmed Optimizing antimicrobial prescribing: Are clinicians following national trends in methicillin-resistant staphylococcus aureus (MRSA) infections rather than local data when treating MRSA wound infections
title_short Optimizing antimicrobial prescribing: Are clinicians following national trends in methicillin-resistant staphylococcus aureus (MRSA) infections rather than local data when treating MRSA wound infections
title_sort optimizing antimicrobial prescribing: are clinicians following national trends in methicillin-resistant staphylococcus aureus (mrsa) infections rather than local data when treating mrsa wound infections
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853220/
https://www.ncbi.nlm.nih.gov/pubmed/24128420
http://dx.doi.org/10.1186/2047-2994-2-28
work_keys_str_mv AT schweizermarinl optimizingantimicrobialprescribingarecliniciansfollowingnationaltrendsinmethicillinresistantstaphylococcusaureusmrsainfectionsratherthanlocaldatawhentreatingmrsawoundinfections
AT perencevichelin optimizingantimicrobialprescribingarecliniciansfollowingnationaltrendsinmethicillinresistantstaphylococcusaureusmrsainfectionsratherthanlocaldatawhentreatingmrsawoundinfections
AT ebermichaelr optimizingantimicrobialprescribingarecliniciansfollowingnationaltrendsinmethicillinresistantstaphylococcusaureusmrsainfectionsratherthanlocaldatawhentreatingmrsawoundinfections
AT caixueya optimizingantimicrobialprescribingarecliniciansfollowingnationaltrendsinmethicillinresistantstaphylococcusaureusmrsainfectionsratherthanlocaldatawhentreatingmrsawoundinfections
AT shardellmichelled optimizingantimicrobialprescribingarecliniciansfollowingnationaltrendsinmethicillinresistantstaphylococcusaureusmrsainfectionsratherthanlocaldatawhentreatingmrsawoundinfections
AT braykovnikolay optimizingantimicrobialprescribingarecliniciansfollowingnationaltrendsinmethicillinresistantstaphylococcusaureusmrsainfectionsratherthanlocaldatawhentreatingmrsawoundinfections
AT laxminarayanramanan optimizingantimicrobialprescribingarecliniciansfollowingnationaltrendsinmethicillinresistantstaphylococcusaureusmrsainfectionsratherthanlocaldatawhentreatingmrsawoundinfections